This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.
In a memo to employees on Tuesday, 23andMe CEO Anne Wojcicki said the company wi...
Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to ente...
Roche presented early-stage data on its obesity injection and pill at EASD. Mean...
The U.S. Food and Drug Administration on Monday cleared Apple's new sleep apnea ...
In updated guidance to health care providers, Florida health officials advise th...
The company called the outbreak a "dark moment" in its history and apologized fo...
Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the las...
Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the las...
Apple is using its newest AirPods Pro as a way to help break into the health ind...
The data sets the stage for likely approval of Gilead's Lenacapavir for HIV prev...
Moderna is deprioritizing certain parts of its pipeline, which involves pausing ...
Deep vein thrombosis can be a serious health issue that strikes at any time. But...
Safi Biotherapeutics, a government-backed startup, is growing blood in a lab to ...
A large swath of insured Americans could be eligible for a popular class of weig...
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop i...
Leqembi's rollout has been slowed by bottlenecks related to reimbursement uncert...